Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Experimental Hematology|February 1, 1981
Dissemination and proliferation of intravenously injected murine, syngeneic T lymphoma cellsS B GjeddeCancer Research|November 1, 1983
Correlation of growth morphology and clonability with malignancy of WEHI-7 T-cell lymphoma sublinesS B GjeddeExperimental Hematology|April 1, 1980
B-lymphocyte colony forming cells in the thymus of AKR miceS B GjeddeActa Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology|April 1, 1983
Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma systemS B GjeddeUgeskrift for Laeger|July 29, 1998
[Parvovirus B19 infection--a meningococcus-like sepsis]E H Frederiksen, S B GjeddeLeukemia & Lymphoma|April 1, 1996
Salvage therapy with fludarabine in patients with progressive B-chronic lymphocytic leukemiaS B Gjedde, M M HansenUgeskrift for Laeger|November 4, 1996
[Chronic lymphatic leukemia. Peroral cladribine as primary treatment]S B Gjedde, G Juliusson, M M HansenEuropean Journal of Cancer & Clinical Oncology|April 1, 1989
Phase II study of tauromustine in disseminated malignant melanomaH Nolte, S B Gjedde, E Lindegaard-Madsen, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
The pharmacokinetics of high-dose epirubicin and of the cardioprotector ADR-529 given together with cyclophosphamide, 5-fluorouracil, and tamoxifen in metastatic breast-cancer patientsP Jakobsen, B Sørensen, L Bastholt, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancerB Sørensen, L Bastholt, M R Mirza, et al.Pageof 2